CN105925558B - 一种用于制备他汀类药物的复合固定化酶及其制备方法 - Google Patents
一种用于制备他汀类药物的复合固定化酶及其制备方法 Download PDFInfo
- Publication number
- CN105925558B CN105925558B CN201610324640.7A CN201610324640A CN105925558B CN 105925558 B CN105925558 B CN 105925558B CN 201610324640 A CN201610324640 A CN 201610324640A CN 105925558 B CN105925558 B CN 105925558B
- Authority
- CN
- China
- Prior art keywords
- enzyme
- buffer solution
- statins
- vector
- organized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 130
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 130
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title claims abstract description 44
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 150000004820 halides Chemical class 0.000 claims abstract description 19
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 239000008055 phosphate buffer solution Substances 0.000 claims description 27
- 239000004593 Epoxy Substances 0.000 claims description 21
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 21
- 239000007853 buffer solution Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 239000000376 reactant Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 230000003139 buffering effect Effects 0.000 claims description 4
- 125000000468 ketone group Chemical group 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 239000012450 pharmaceutical intermediate Substances 0.000 claims 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract description 5
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 abstract description 5
- 229960005370 atorvastatin Drugs 0.000 abstract description 5
- 239000002699 waste material Substances 0.000 abstract description 4
- 238000004132 cross linking Methods 0.000 abstract description 2
- 229960002797 pitavastatin Drugs 0.000 abstract description 2
- VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 abstract description 2
- 229960000672 rosuvastatin Drugs 0.000 abstract description 2
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 7
- 229950006238 nadide Drugs 0.000 description 7
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical compound [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229940002661 lipitor Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000007039 two-step reaction Methods 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- ADZQCEUEGXRCJY-SCSAIBSYSA-N (3r)-4-cyano-3-hydroxybutanoic acid Chemical compound N#CC[C@@H](O)CC(O)=O ADZQCEUEGXRCJY-SCSAIBSYSA-N 0.000 description 1
- 102000006991 Apolipoprotein B-100 Human genes 0.000 description 1
- 108010008150 Apolipoprotein B-100 Proteins 0.000 description 1
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 229940123934 Reductase inhibitor Drugs 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940066901 crestor Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 238000011165 process development Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- LALFOYNTGMUKGG-BGRFNVSISA-L rosuvastatin calcium Chemical compound [Ca+2].CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O.CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O LALFOYNTGMUKGG-BGRFNVSISA-L 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036259 sexual stimuli Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01184—Carbonyl reductase (NADPH) (1.1.1.184)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y405/00—Carbon-halide lyases (4.5)
- C12Y405/01—Carbon-halide lyases (4.5.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610324640.7A CN105925558B (zh) | 2016-05-17 | 2016-05-17 | 一种用于制备他汀类药物的复合固定化酶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610324640.7A CN105925558B (zh) | 2016-05-17 | 2016-05-17 | 一种用于制备他汀类药物的复合固定化酶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105925558A CN105925558A (zh) | 2016-09-07 |
CN105925558B true CN105925558B (zh) | 2019-06-28 |
Family
ID=56841119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610324640.7A Active CN105925558B (zh) | 2016-05-17 | 2016-05-17 | 一种用于制备他汀类药物的复合固定化酶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105925558B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106480009B (zh) * | 2016-12-25 | 2020-12-11 | 河北周酶生物科技有限公司 | 一种固定化氨基酸酯酰转移酶及在制备丙谷二肽中的应用 |
CN109913514A (zh) * | 2019-03-12 | 2019-06-21 | 江苏理工学院 | 一种固定化酶流化床连续催化合成ats-7的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102605011A (zh) * | 2012-03-16 | 2012-07-25 | 苏州汉酶生物技术有限公司 | 一种(s)-4-氯-3-羟基丁酸乙酯的生物制备方法 |
CN104988132A (zh) * | 2015-06-19 | 2015-10-21 | 杭州师范大学 | 一种醛酮还原酶和葡萄糖脱氢酶的微波辅助共固定化方法 |
CN105132488A (zh) * | 2015-09-22 | 2015-12-09 | 江苏理工学院 | (r)-4-氰基-3-羟基丁酸乙酯的制备方法 |
CN105368886A (zh) * | 2015-12-11 | 2016-03-02 | 江苏万年长药业有限公司 | 一种树脂固定卤醇脱卤酶催化合成(r)-4-氰基-3-羟基丁酸乙酯的工艺 |
-
2016
- 2016-05-17 CN CN201610324640.7A patent/CN105925558B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102605011A (zh) * | 2012-03-16 | 2012-07-25 | 苏州汉酶生物技术有限公司 | 一种(s)-4-氯-3-羟基丁酸乙酯的生物制备方法 |
CN104988132A (zh) * | 2015-06-19 | 2015-10-21 | 杭州师范大学 | 一种醛酮还原酶和葡萄糖脱氢酶的微波辅助共固定化方法 |
CN105132488A (zh) * | 2015-09-22 | 2015-12-09 | 江苏理工学院 | (r)-4-氰基-3-羟基丁酸乙酯的制备方法 |
CN105368886A (zh) * | 2015-12-11 | 2016-03-02 | 江苏万年长药业有限公司 | 一种树脂固定卤醇脱卤酶催化合成(r)-4-氰基-3-羟基丁酸乙酯的工艺 |
Non-Patent Citations (2)
Title |
---|
卤醇脱卤酶HheC的固定化研究;孙恒飞;《中国优秀硕士学位论文全文数据库 基础科技辑》;20160315(第03期);摘要,第13页第4-5段,第31页第3段,第33页第2段 |
氨基功能载体固定化酶研究进展;许敬亮等;《化工进展》;20101231;第29卷(第3期);第494-497页 |
Also Published As
Publication number | Publication date |
---|---|
CN105925558A (zh) | 2016-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Castro et al. | Microbial co-culturing strategies for fructo-oligosaccharide production | |
Wang et al. | Synthesis of benzyl cinnamate by enzymatic esterification of cinnamic acid | |
AU2021201921B2 (en) | Polyunsaturated fatty acid triglyceride and preparation and uses thereof | |
JP5090910B2 (ja) | 光学活性2−(n−置換アミノメチル)−3−ヒドロキシ酪酸エステル類の製造方法 | |
CN104774881B (zh) | 一种生物催化生产L-α-氨基丁酸的方法 | |
JP7169025B2 (ja) | 酵素によるキラル化合物の分割方法 | |
CN104673870B (zh) | 固定化酯酶E.coli BioH催化合成维生素A棕榈酸酯的方法 | |
CN105925558B (zh) | 一种用于制备他汀类药物的复合固定化酶及其制备方法 | |
WO2024078646A1 (zh) | 一种酶化学法制备(r)-戊唑醇的方法 | |
CN106834372A (zh) | 一种转氨酶生物催化制备(s)‑或(r)‑2‑氨基丁酰胺的方法 | |
CN101104861B (zh) | 生物催化制备s-布洛芬及s-布洛芬酯的方法 | |
Zhang et al. | Efficient anti-Prelog enantioselective reduction of acetyltrimethylsilane to (R)-1-trimethylsilylethanol by immobilized Candida parapsilosis CCTCC M203011 cells in ionic liquid-based biphasic systems | |
CN108285908B (zh) | 一种固定化双酶催化合成(s)-1-(2,6-二氯-3-氟-苯基)乙醇的方法 | |
CN101671639B (zh) | 一种苏云金芽孢杆菌及其l-薄荷醇的制备方法 | |
CN102947461A (zh) | 通过环己烷-1,2-二羧酸二甲酯的催化生物拆分制备(3aS,7aR)-六氢异苯并呋喃-1(3H)-酮 | |
JP2010532992A (ja) | 3,4−エポキシ酪酸エチルの微生物速度論的分割 | |
CN101054597A (zh) | 一种微生物转化生产胱氨酸的方法 | |
CN101665443A (zh) | 氨基酸邓盐的制备方法 | |
CN100385007C (zh) | 一种微生物不对称拆分制备(r)-扁桃酸的方法 | |
CN105316369A (zh) | 一种海藻酸钠固定卤醇脱卤酶催化合成(r)-4-氰基-3-羟基丁酸乙酯的工艺 | |
CN112921064A (zh) | 一种固定化酶催化合成维生素a棕榈酸酯的方法 | |
CN111607625B (zh) | 一种酶法生产抗坏血酸棕榈酸酯的方法 | |
KR102565303B1 (ko) | 무용매 조건 하에서 고정화 효소를 이용한 에틸헥실 지방산 에스터의 합성방법 | |
IT8050073A1 (it) | PROCEDIMENTO PER PRODURRE ACIDO D(-)-β-IDROSSI-ISOBUTIRRICO. | |
CN103305584B (zh) | 一种酶催化拆分光学纯2-辛醇的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240313 Address after: Room 403, 4th Floor, Building 4, Jide Science and Technology Park, No. 196 Hengshan Street, High tech Zone, Shijiazhuang City, Hebei Province, 050000 Patentee after: HEBEI ZHOUMEI BIOTECHNOLOGY Co.,Ltd. Country or region after: China Patentee after: Hebei Amino Amino Acid Technology Co.,Ltd. Address before: No.02, 5th Floor, Building 5, Zone C, Fangyi Science and Technology Park, High tech Zone, Shijiazhuang City, Hebei Province, 050000 Patentee before: HEBEI ZHOUMEI BIOTECHNOLOGY Co.,Ltd. Country or region before: China |